ASMB Quote, Trading Chart, Assembly Biosciences Inc.
home / stock / asmb / asmb quote
$3.30 Last:
1.23% Change Percent:
$3.26 Open:
$3.30 Previous Close:
$3.3 High:
$3.25 Low:
419,408 Volume:
09/23/2021 04:56:26 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
ASMB Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-09-23 | 3.26 | 3.3 | 3.3 | 3.25 | 419,408 |
| 2021-09-22 | 3.23 | 3.26 | 3.28 | 3.23 | 328,235 |
| 2021-09-21 | 3.24 | 3.24 | 3.29 | 3.23 | 573,160 |
| 2021-09-20 | 3.22 | 3.25 | 3.27 | 3.145 | 457,477 |
| 2021-09-17 | 3.2 | 3.23 | 3.265 | 3.2 | 682,075 |
| 2021-09-16 | 3.22 | 3.22 | 3.23 | 3.16 | 353,821 |
| 2021-09-15 | 3.24 | 3.2 | 3.26 | 3.169 | 689,049 |
| 2021-09-14 | 3.29 | 3.26 | 3.36 | 3.175 | 922,298 |
| 2021-09-13 | 3.22 | 3.3 | 3.47 | 3.155 | 1,020,565 |
| 2021-09-10 | 3.17 | 3.23 | 3.26 | 3.09 | 750,933 |
| 2021-09-09 | 3.13 | 3.14 | 3.17 | 3.09 | 861,601 |
| 2021-09-08 | 3.22 | 3.16 | 3.235 | 3.12 | 833,868 |
| 2021-09-07 | 3.2253 | 3.2 | 3.2593 | 3.15 | 1,067,530 |
| 2021-09-06 | 3.25 | 3.26 | 3.28 | 3.1726 | 1,213,170 |
| 2021-09-03 | 3.25 | 3.26 | 3.28 | 3.1726 | 1,206,055 |
| 2021-09-02 | 3.15 | 3.27 | 3.3 | 3.09 | 4,141,464 |
| 2021-09-01 | 3.81 | 3.9 | 3.94 | 3.785 | 905,464 |
| 2021-08-31 | 3.69 | 3.8 | 3.87 | 3.67 | 834,716 |
| 2021-08-30 | 3.71 | 3.68 | 3.715 | 3.65 | 449,102 |
| 2021-08-27 | 3.69 | 3.67 | 3.74 | 3.62 | 674,148 |
Assembly Biosciences Inc. Company Name:
ASMB Stock Symbol:
NASDAQ Market:
Assembly Biosciences Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
--Decision follows observation of elevated alanine transaminase (ALT) levels in Phase 2 study --Company will focus on advancing ongoing triple combination studies and earlier pipeline candidates SOUTH SAN FRANCISCO, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Assembly Biosc...
-
SOUTH SAN FRANCISCO, Calif., Aug. 18, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today announced it has selected a fourth core inhibitor candidate, ABI-4334 ...
-
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today reported financial results and recent highlights for the second ...